Skip header and navigation

Narrow By

2 records – page 1 of 1.

Pulmonary Artery Hypertension (PAH) Program

https://libcat.nshealth.ca/en/permalink/chpams34865
Nova Scotia Health Authority. Pulmonary Arterial Hypertension Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1103
Available Online
View Pamphlet
The Pulmonary Arterial Hypertension (PAH) Program coordinates the assessment, care, and treatment of people with suspected or diagnosed pulmonary arterial hypertension. This pamphlet describes PAH, a rare condition that causes high blood pressure in the blood vessels that connect the heart and lungs (pulmonary arteries). This pamphlet explains what causes PAH, why you have been referred to the PAH Program, how the PAH Program will help you, what tests will be done, and how PAH is treated. A lis…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pulmonary Arterial Hypertension Program
Alternate Title
PAH Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.): digital, PDF file
Subjects (MeSH)
Familial Primary Pulmonary Hypertension
Cardiovascular Diseases - diagnosis
Subjects (LCSH)
Pulmonary hypertension
Cardiovascular system--Diseases--Diagnosis
Abstract
The Pulmonary Arterial Hypertension (PAH) Program coordinates the assessment, care, and treatment of people with suspected or diagnosed pulmonary arterial hypertension. This pamphlet describes PAH, a rare condition that causes high blood pressure in the blood vessels that connect the heart and lungs (pulmonary arteries). This pamphlet explains what causes PAH, why you have been referred to the PAH Program, how the PAH Program will help you, what tests will be done, and how PAH is treated. A list of resources for more information is included.
Responsibility
Prepared by: Pulmonary Arterial Hypertension Program
Pamphlet Number
1103
Less detail

Sclerotherapy discharge instructions - Dr. MacKean

https://libcat.nshealth.ca/en/permalink/chpams35640
Nova Scotia Health Authority. QEII. Minor Procedures. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0206
Available Online
View Pamphlet
Your varicose veins have been injected with a special medication during a treatment called sclerotherapy. This medication causes a blockage in your varicose veins. This forces the blood to go around the blockage and travel through nearby healthier veins, increasing blood flow in your legs. This pamphlet gives specific directions to prevent blood clots from forming in your healthy veins. Mild side effects and a list of symptoms that require immediate medical attention are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Minor Procedures
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sclerotherapy
Subjects (LCSH)
Sclerotherapy
Specialty
Cardiovascular System
Abstract
Your varicose veins have been injected with a special medication during a treatment called sclerotherapy. This medication causes a blockage in your varicose veins. This forces the blood to go around the blockage and travel through nearby healthier veins, increasing blood flow in your legs. This pamphlet gives specific directions to prevent blood clots from forming in your healthy veins. Mild side effects and a list of symptoms that require immediate medical attention are provided.
Responsibility
Prepared by: Minor Procedures & G. MacKean MD, QEII, Halifax
Pamphlet Number
0206
Less detail